GASTRIC MUCOSAL HYPERTROPHY

This adverse event was reported 247 times

These drugs are most commonly taken by patients reporting GASTRIC MUCOSAL HYPERTROPHY:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 42
1 OMEPRAZOLE 35
2 ESOMEPRAZOLE MAGNESIUM 20
3 FUROSEMIDE 20
4 ACETAMINOPHEN 15
5 ADALIMUMAB 15
6 IBUPROFEN 15
7 METHOTREXATE SODIUM 15
8 ASPIRIN 14
9 ASPIRIN 325 MG 13
See all common drugs associated with GASTRIC MUCOSAL HYPERTROPHY

GASTRIC MUCOSAL HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM 1 0.0027
1 ORPHENADRINE CITRATE 1 0.0016
2 AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE 1 0.0015
3 LANTHANUM CARBONATE 6 0.0012
4 VONOPRAZAN FUMARATE 9 0.0011
5 COLESEVELAM HYDROCHLORIDE 1 0.0009
6 PSYLLIUM HUSK 1 0.0007
7 POTASSIUM ACETATE 1 0.0007
8 CALCIUM POLYCARBOPHIL 2 0.0007
9 ZOLBETUXIMAB 1 0.0007
See all drugs enriched for association with GASTRIC MUCOSAL HYPERTROPHY

GASTRIC MUCOSAL HYPERTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Claudin 18.2-directed Cytolytic Antibody [EPC] 1 0.0007
1 GLP-2 Analog [EPC] 8 0.0006
2 Blood Viscosity Reducer [EPC] 1 0.0002
3 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
4 Vitamin D2 Analog [EPC] 1 0.0001
5 Provitamin D2 Compound [EPC] 4 0.0001
6 Cannabinoid [EPC] 1 0.0001
7 Antimalarial [EPC] 1 0.0001
8 Antiprotozoal [EPC] 1 0.0001
9 Proton Pump Inhibitor [EPC] 51 0.0001
See all drug classes enriched for association with GASTRIC MUCOSAL HYPERTROPHY